Healthcare & Medical Devices Global On demand · 24-48h

Global Polyisoprene Surgical Gloves Market Strategic Research Report

Global Polyisoprene Surgical Gloves Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Polyisoprene Surgical Gloves Market
$2432025
6.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Standard Type, Micro (ultra-thin), Orthopedic (thick)

By Application: Hospital, Clinic, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: HARPS Holdings, Cardinal Health, Hartalega Holdings Berhad, Motex Healthcare Corp., WRP Asia Pacific Sdn. Bhd, Top Glove Corporation Bhd, HBM Protection, O&M Halyard, Ansell Limited, Mölnlycke Health Care AB, Sanko Kagaku Co., Ltd., Bimedica

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 108 pages
Market size 2025
$243
Million USD
Forecast CAGR
6.4%
2025-2032
Forecast 2032
$375.1
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Polyisoprene Surgical Gloves market size is predicted to grow from US$ 243 million in 2025 to US$ 373 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.

In the medical industry, gloves are essential protective equipment for medical staff and play a vital role. They not only play a key role in surgical operations, but also effectively reduce the risk of bacterial infection and sharp punctures. When medical staff come into contact with patients, medical gloves are a strong guarantee for their safety, which can effectively isolate germs and prevent cross infection.

In recent years, the field of medical protection has ushered in a new type of medical gloves - polyisoprene surgical gloves, referred to as PI gloves. PI gloves use high-quality polyisoprene (PI) as raw material to create protective performance comparable to natural latex surgical gloves. It provides a solid guarantee for surgical operations, effectively protects the safety of patients and users, and helps reduce the risk of cross infection.

The current global market size of polyisoprene surgical gloves is relatively small, mainly dominated by a few raw material manufacturers such as Zeon and Cariflex and a few downstream high-end glove manufacturers. The price is much higher than natural latex and nitrile gloves, mainly meeting the needs of high-end hospitals and specific departments in developed regions such as Europe and the United States. Against the backdrop of the gradual implementation of domestic raw material localization and the continuous improvement of production processes, polyisoprene gloves are expected to break the dependence on imported raw materials and technologies, complete the localized supply closed loop, and accelerate entry into the high-end European and American markets through overseas registration and certification, realizing import substitution and value-added export dual-wheel drive. In response to trade barriers and geopolitical uncertainties, leading companies are accelerating the layout of production bases in Southeast Asia, Latin America and other places, while paying attention to the next generation of high-end latex-free protein materials similar to polyisoprene, such as functionalized synthetic latex, degradable biomaterials, etc., to maintain the dual leadership of material upgrades and cost optimization.

As the global medical industry continues to pay more attention to the risk of allergies to natural latex proteins, polyisoprene gloves have become the preferred alternative for many high-end specialties such as cardiac surgery and neurosurgery in scenarios where operation sensitivity is extremely high, thanks to their comfort and elasticity that are extremely similar to natural latex. They effectively fill the gap in comfort of traditional materials such as nitrile and chloroprene. The original positioning of polyisoprene surgical gloves was to meet the needs of high-end hospitals in developed countries for low-allergenicity and high-comfort specialty surgeries. This attribute determines its high price range, concentrated customer base and stable purchasing intention. In the post-epidemic era, the disposable protective glove industry has entered a stage of destocking and de-low-endization. Global hospitals and medical staff have relatively rigid budgets for hospital infection safety and are willing to pay for differentiated performance. The logic of polyisoprene's "high-end, low-sensitivity alternative" has become increasingly prominent.

This report presents a comprehensive overview of the global Polyisoprene Surgical Gloves market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Standard Type
  • Micro (ultra-thin)
  • Orthopedic (thick)

Segment by Size

  • 6
  • 6.5
  • 7
  • 7.5
  • 8
  • Other Size

Segment by Application

  • Hospital
  • Clinic
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Polyisoprene Surgical Gloves market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Polyisoprene Surgical Gloves Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$243
2025
Forecast
$375.1
2032
CAGR
6.4%
2025–2032
Regions
5
global
Key companies
HARPS HoldingsCardinal HealthHartalega Holdings BerhadMotex Healthcare Corp.WRP Asia Pacific Sdn. BhdTop Glove Corporation BhdHBM ProtectionO&M Halyard
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Standard TypeMicro (ultra-thin)Orthopedic (thick)
By Application
HospitalClinicOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Standard Type
  • 3.1.3 Micro (ultra-thin)
  • 3.1.4 Orthopedic (thick)
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 HARPS Holdings
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Cardinal Health
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Hartalega Holdings Berhad
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Motex Healthcare Corp.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 WRP Asia Pacific Sdn. Bhd
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Top Glove Corporation Bhd
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 HBM Protection
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 O&M Halyard
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Ansell Limited
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Mölnlycke Health Care AB
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Sanko Kagaku Co., Ltd.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Bimedica
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Polyisoprene Surgical Gloves market?
The global Polyisoprene Surgical Gloves market is estimated at US$ 243 million in 2025 (base year) and is projected to reach US$ 373 million by 2032.
What is the forecast CAGR for the Polyisoprene Surgical Gloves market?
The market is expected to grow at a CAGR of 6.4% from 2026 to 2032, expanding from US$ 243 million in 2025 to US$ 373 million in 2032, roughly 1.5 times its base-year value.
What is Polyisoprene Surgical Gloves?
In the medical industry, gloves are essential protective equipment for medical staff and play a vital role. They not only play a key role in surgical operations, but also effectively reduce the risk of bacterial infection and sharp punctures. When medical staff come into contact with patients, medical gloves are a strong guarantee for their safety, which can effectively isolate germs and prevent cross infection.
What are the main segments of the Polyisoprene Surgical Gloves market by type?
By type, the market is segmented into Standard Type, Micro (ultra-thin) and Orthopedic (thick).
Which applications drive demand in the Polyisoprene Surgical Gloves market?
Key applications covered include Hospital, Clinic and Other.
Who are the key players in the Polyisoprene Surgical Gloves market?
Key players profiled include HARPS Holdings, Cardinal Health, Hartalega Holdings Berhad, Motex Healthcare Corp., WRP Asia Pacific Sdn. Bhd, Top Glove Corporation Bhd, HBM Protection and O&M Halyard, among 12 companies covered in total.
Which regions and countries are covered for Polyisoprene Surgical Gloves?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Polyisoprene Surgical Gloves market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Clinic and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Polyisoprene Surgical Gloves market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.